Shire Wins Adderall Suit While Loser Gets Sanction Request
Shire PLC prevailed on patent claims Thursday over a small pharmaceutical company that withheld data until midtrial showing how closely its generic product resembled hit hyperactivity treatment Adderall XR, misconduct that...To view the full article, register now.
Already a subscriber? Click here to view full article